^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    IL-13Rα2 UCAR-T cell therapy

    i
    Other names: IL-13Rα2 UCAR-T cell therapy, MT-026
    Associations
    News
    Trials
    Company:
    Suzhou Maximum Bio-tech
    Drug class:
    IL-13Rα2-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News
    Trials